Post-earnings recap
Reported
Thu, Aug 6, 2015
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio Rad Laboratories reported better-than-expected earnings per share, which indicates strong cost management or operational efficiency. However, the stock fell by nearly 3% on the day, likely due to the lack of revenue guidance and uncertainty about future performance. Investors may be cautious as the company did not provide additional insights into its revenue outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.97 | N/A | +25.16% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting a strong performance. However, they did not provide any specific guidance for future revenue.
We are pleased with our EPS performance this quarter.
While we did not provide revenue guidance, we remain focused on our long-term growth strategy.